- **Revenue Decline**: Q1 revenue down 5% YoY due to NEMT contract losses and lower PCS hours.
- **Cost Savings Progress**: $25M G&A savings target, with $8M impact from contract repricing.
- **Cash Flow Concerns**: Negative free cash flow ($86.2M) in Q1, but April collections improved by $30M.
- **Strategic Focus**: Accelerating automation, reducing shared-risk contracts, and exploring divestitures to improve capital efficiency.

**【CEO Strategic Objectives Overview】**
- **5 Core Objectives**: Grow customer relationships, digitize platforms, optimize operations, improve capital efficiency, and deliver client-centric care.
- **NEMT Wins**: Secured $52M in new contracts, with $38M in-year revenue, and submitted $246M in renewals.
- **Pipeline Strength**: 2026 pipeline exceeds $500M in potential contract value.
- **Loss Mitigation**: Lost $15M contract due to vendor consolidation, highlighting retention focus.

**【Financial Results】**
- **Revenue**: $650.7M (-5% YoY), driven by NEMT contract attrition and lower PCS hours.
- **Net Loss**: $50.4M (up from $22.3M YoY) due to higher interest expenses.
- **Adjusted EBITDA**: $32.6M (flat YoY), with NEMT margin improving to 6.2%.
- **Key Metrics**: Revenue per member/month up 16% YoY to $6.35, Monitoring referrals +45% YoY in Indiana.

**【Q&A Highlights】**
- **Cash Flow Challenges**: Q1 free cash flow negative ($86.2M) due to working capital build, but April collections improved by $30M.
- **Contract Receivables**: AR rose $109M YoY due to shared-risk contracts, expected to stabilize with 2026 contract restructuring.
- **G&A Savings**: $25M annualized target, primarily from labor reductions in corporate and shared services.
- **Strategic Alternatives**: Board committee evaluating divestitures, with Monitoring segment nearing readiness for separation.

ModivCare (MODV)-8 May 25-2025 Q1 Earnings call transcript

- **Revenue Resilience**: Full-year revenue of $2.8 billion despite 2024 Medicaid disruptions, with Q4 flat at $702.8 million.
- **Strategic Capital Raise**: Secured $105 million in new debt to strengthen liquidity and support transformation.
- **Segment Strength**: Monitoring segment drives 16% of EBITDA, with advanced technology and recurring revenue streams.
- **Contract Transition**: 25% of NEMT revenue now fee-for-service, reducing utilization risk and improving cash flow timing.
- **Key Risks**: $200 million annual revenue loss from contract attrition, partially offset by new wins expected in 2025.

**【CEO Summary Section】**
- **2024 Challenges and Recovery**: Faced unprecedented disruptions from Medicaid redetermination, MA reimbursement cuts, and market volatility. Revenue for 2024 was $2.8 billion, with Q4 revenue at $702.8 million. Adjusted EBITDA for the year was $161.1 million, down 20% due to external pressures.
- **Strategic Initiatives**: Secured $75 million term loan and $30 million second lien notes to strengthen capital position. Appointed Chad Shandler as Chief Transformation Officer and added Alec Cunningham and David Mounts Gonzales to the Board for strategic expertise.
- **Segment Growth**: NEMT remains the largest segment (70% of revenue), with 29.4 million average monthly members in Q4. PCS and Monitoring segments showed steady improvement, with Monitoring contributing 16% of adjusted EBITDA.
- **Contract Shifts**: Transitioning to fee-for-service contracts to reduce utilization risk, with 25% of revenue now under this model. Lost $200 million in annual revenue from contract attrition but expect recovery through new wins in 2025.

**【CFO Financial Commentary】**
- **Financial Performance**: Full-year revenue grew 1% to $2.79 billion, with NEMT flat year-over-year and PCS up 4.1%. Q4 adjusted EBITDA was $40.4 million (5.7% of revenue), driven by cost-saving initiatives ($35 million in 2024 savings).
- **Liquidity and Capital**: Ended 2024 with $113 million in cash and $269 million drawn on revolver. Free cash flow in Q4 was $24.7 million, with net contract receivables at $95.2 million.
- **Segment Metrics**: NEMT gross margin decreased 16 basis points to 11.2%, while Monitoring maintained a 35% EBITDA margin. PCS adjusted EBITDA was $17.5 million, boosted by state quality incentives.

**【Q&A Highlights】**
- **Medicaid Budget Risks**: CEO noted LTSS members (Personal Care and Monitoring) are less affected by Medicaid cuts. Fee-for-service contracts mitigate risk, with 20% of NEMT in shared risk.
- **Asset Sales Progress**: Monitoring platform discussions are advanced, with interest from buyers. PCS and NEMT monetization efforts are ongoing.
- **Cash Flow Outlook**: Expect first-half 2025 cash flow use due to shared risk contracts, transitioning to positive free cash flow in H2 as fee-for-service占比 increases.
- **Matrix Medical Update**: Management is focused on operational efficiency, with no immediate sale plans. Pennsylvania reimbursement rate increases could benefit PCS.
- **Contract Renewals**: Largest state contract RFP expected in 2025, with pricing adjustments underway to reflect post-redetermination member mix.

ModivCare (MODV)-6 Mar 25-2024 Q4 Earnings call transcript

ModivCare (MODV)-3 May 24-2024 Q1 Earnings call transcript

ModivCare Inc. (MODV) Q4 2023 Earnings Call Transcript

ModivCare (MODV)-3 Nov 23-2023 Q3 Earnings call transcript

ModivCare (MODV)-4 Aug 23-2023 Q2 Earnings call transcript

ModivCare (MODV)-4 May 23-2023 Q1 Earnings call transcript

ModivCare (MODV)-23 Feb 23-2022 Q4 Earnings call transcript

ModivCare (MODV)-7 Aug 22-2022 Q2 Earnings call transcript

ModivCare (MODV)-7 May 22-2022 Q1 Earnings call transcript

ModivCare (MODV)-25 Feb 22-2021 Q4 Earnings call transcript

ModivCare (MODV)-5 Nov 21-2021 Q3 Earnings call transcript

ModivCare (MODV)-8 Aug 21-2021 Q2 Earnings call transcript

ModivCare (MODV)-9 May 21-2021 Q1 Earnings call transcript

ModivCare (MODV)-7 Nov 20-2020 Q3 Earnings call transcript

- **Record EBITDA Growth**: Q2 EBITDA up 913% YoY to $56.4M, driven by operational efficiency and National MedTrans acquisition.
- **Strategic Tech Investments**: Launched member app for real-time ride tracking, optimizing contact centers with IVR and BPO partners.
- **COVID-19 Resilience**: Expanded food delivery to 11,700+ meals, maintaining network health with bridge loans and quality monitoring.
- **Medicare Advantage Expansion**: Acquired $50M Medicare Advantage revenue via National MedTrans, aligning with UnitedHealthcare growth trends.
- **Cash Strength**: $108.4M operating cash flow used to de-leverage and fund strategic initiatives, with no debt on balance sheet.

**【CEO Opening Remarks】**
- **EBITDA Growth**: Q2 EBITDA of $56.4M vs. $5.8M YoY, driven by operational improvements under the 6-pillar strategy and National MedTrans acquisition.
- **6-Pillar Strategy**: Focus on customer voice, talent placement, tech enhancements, contact center optimization, rebranding, and growth. Launched a member app for real-time ride tracking in August.
- **COVID-19 Response**: Expanded food delivery partnerships (e.g., Philabundance, Miami-Dade Schools) to support 11,700+ meals and sustain transportation networks.
- **Acquisition**: National MedTrans ($80M) added $50M Medicare Advantage revenue; seamless migration onto Providence platform.
- **Future Outlook**: Anticipates higher utilization in H2 but expects durable cost savings. No formal guidance due to COVID-19 uncertainty.

**【CFO Financial Commentary】**
- **Revenue**: $282.3M (Q2 2020) vs. $363.9M (Q2 2019), down 28% due to lower truck volume but offset by National MedTrans.
- **Gross Margin**: 46.3% (Q2 2020) vs. 18.3% (Q2 2019), driven by lower utilization. Anticipates decline in H2 with higher utilization.
- **Operating Expenses**: 26.3% of revenue (Q2 2020) vs. 16.7% (Q2 2019), up due to tech investments, equity awards, and MedTrans transition costs.
- **Adjusted EBITDA**: $56.4M, net income $38M, or $2.53/diluted share.
- **Cash Flow**: $108.4M from operations, used to pay down debt and fund preferred stock conversion.
- **Matrix Performance**: Q2 revenue $90.7M, EBITDA $32.6M, up YoY. Launched telehealth alternative for home assessments.

**【Q&A Highlights】**
- **Utilization Trends**: Expect incremental increases in H2, but not back to pre-COVID levels. Higher unit costs due to COVID safety measures.
- **Transportation Network Health**: Strengthened through food delivery partnerships, bridge loans, and quality monitoring (Net Promoter Scores).
- **Medicaid Growth**: Anticipate 7-10% enrollment growth, with 1M+ new members YTD. Medicare Advantage expansion seen as key growth driver.
- **Cash Priorities**: Tech investments (IVR, BPO), strategic acquisitions, and share buybacks. No debt; strong balance sheet for opportunistic moves.
- **Contract Adjustments**: 85% capitated, 15% transactional. COVID caused $65M working capital adjustment, to be paid back over 1-2 years.
- **Matrix Outlook**: Improved performance sustainable; 43% ownership may unlock value as UnitedHealthcare partnership grows.


MODV(Delisted)

MODV fundamentals

Earnings Call

You can ask Aime